Matthew Wiley

Equibles does not estimate personal net worth.

Get an email with a short summary when Yarrow Bioscience, Inc. publishes a filing, an earnings call transcript or a press release.

Get YARW alerts

About Matthew Wiley

Matthew Wiley has spoken on 1 earnings call across 1 company, most recently for Yarrow Bioscience, Inc. on November 5, 2020. Yarrow Bioscience, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Yarrow Bioscience, Inc. includes Rebecca Frey (CEO and Board Member), Bill Lundberg (Chairman and Board Member), Andrew Saik (CFO) and 7 others.

Matthew Wiley on recent calls

“We are pleased with the commercial execution for both AMZEEQ and the recent launch of ZILXI into the rosacea market.”

CFO, VYNE Therapeutics Inc. Q3 FY2020 Earnings Call · November 5, 2020

Affiliation history

Yarrow Bioscience, Inc. (YARW)
Proxy statement

Current
Start not stated–present

Last confirmed June 7, 2021

Company network

Yarrow Bioscience, Inc.

YARW

Current role

Biotechnology · Healthcare

1 appearance Latest appearance 2020-11-05

View calls and events

Leadership on record at Yarrow Bioscience, Inc.

Rebecca Frey CEO, Board Member
Bill Lundberg Chairman, Board Member
Andrew Saik CFO
Ilan Hadar CFO
Tyler Zeronda CFO
Rachael Alford COO
Iain Stuart CTO
David Domzalski Board Member
Dr. Christine Borowski Board Member
Mona Ashiya Board Member

Recent activity

Earnings call VYNE Therapeutics Inc. Q3 FY2020 Earnings Call Yarrow Bioscience, Inc. (YARW)
2020-11-05